131 related articles for article (PubMed ID: 15207808)
1. Metabolism of 2-methyladenosine in Mycobacterium tuberculosis.
Parker WB; Barrow EW; Allan PW; Shaddix SC; Long MC; Barrow WW; Bansal N; Maddry JA
Tuberculosis (Edinb); 2004; 84(5):327-36. PubMed ID: 15207808
[TBL] [Abstract][Full Text] [Related]
2. The metabolism of 2-methyladenosine in Mycobacterium smegmatis.
Chen CK; Barrow EW; Allan PW; Bansal N; Maddry JA; Suling WJ; Barrow WW; Parker WB
Microbiology (Reading); 2002 Jan; 148(Pt 1):289-295. PubMed ID: 11782521
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety.
Long MC; Parker WB
Biochem Pharmacol; 2006 Jun; 71(12):1671-82. PubMed ID: 16620788
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth.
Long MC; Allan PW; Luo MZ; Liu MC; Sartorelli AC; Parker WB
J Antimicrob Chemother; 2007 Jan; 59(1):118-21. PubMed ID: 17085766
[TBL] [Abstract][Full Text] [Related]
5. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial activity of 2-methyl-adenosine.
Barrow EW; Westbrook L; Bansal N; Suling WJ; Maddry JA; Parker WB; Barrow WW
J Antimicrob Chemother; 2003 Nov; 52(5):801-8. PubMed ID: 14563890
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosis.
Long MC; Escuyer V; Parker WB
J Bacteriol; 2003 Nov; 185(22):6548-55. PubMed ID: 14594827
[TBL] [Abstract][Full Text] [Related]
8. Differences in the metabolism and metabolic effects of the carbocyclic adenosine analogs, neplanocin A and aristeromycin.
Bennett LL; Allan PW; Rose LM; Comber RN; Secrist JA
Mol Pharmacol; 1986 Apr; 29(4):383-90. PubMed ID: 3702857
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory effect and apoptosis induced by extracellular ATP and adenosine on human gastric carcinoma cells: involvement of intracellular uptake of adenosine.
Wang MX; Ren LM
Acta Pharmacol Sin; 2006 Aug; 27(8):1085-92. PubMed ID: 16867263
[TBL] [Abstract][Full Text] [Related]
10. Purine metabolism in Mycobacterium tuberculosis as a target for drug development.
Parker WB; Long MC
Curr Pharm Des; 2007; 13(6):599-608. PubMed ID: 17346177
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis II. Modifications to the ribofuranosyl moiety.
Long MC; Shaddix SC; Moukha-Chafiq O; Maddry JA; Nagy L; Parker WB
Biochem Pharmacol; 2008 Apr; 75(8):1588-600. PubMed ID: 18329005
[TBL] [Abstract][Full Text] [Related]
12. 2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism.
Saito T; Yamaguchi J
J Immunol; 1985 Mar; 134(3):1815-22. PubMed ID: 3968433
[TBL] [Abstract][Full Text] [Related]
13. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
15. 2-Oxoadenosine induces cytotoxicity through intracellular accumulation of 2-oxo-ATP and depletion of ATP but not via the p38 MAPK pathway.
Asada S; Ohta E; Akimoto Y; Abolhassani N; Tsuchimoto D; Nakabeppu Y
Sci Rep; 2017 Jul; 7(1):6528. PubMed ID: 28747712
[TBL] [Abstract][Full Text] [Related]
16. Differential response of Drosophila cell lines to extracellular adenosine.
Fleischmannova J; Kucerova L; Sandova K; Steinbauerova V; Broz V; Simek P; Zurovec M
Insect Biochem Mol Biol; 2012 May; 42(5):321-31. PubMed ID: 22266077
[TBL] [Abstract][Full Text] [Related]
17. Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes.
Zamzow CR; Xiong W; Parkinson FE
J Neurosci Res; 2008 Nov; 86(15):3447-55. PubMed ID: 18627033
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between the signaling pathways triggered by angiotensin II and adenosine in the renal proximal tubules: implications for modulation of Na(+)-ATPase activity.
Gomes CP; Leão-Ferreira LR; Pinheiro AA; Gomes-Quintana E; Wengert M; Lopes AG; Caruso-Neves C
Peptides; 2008 Nov; 29(11):2033-8. PubMed ID: 18682265
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase C is involved in the adenosine-activated signal transduction pathway conferring protection against iodoacetic acid-induced injury in primary rat neuronal cultures.
Rogel A; Bromberg Y; Sperling O; Zoref-Shani E
Neurosci Lett; 2005 Jan; 373(3):218-21. PubMed ID: 15619546
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells.
Yang SY; Jia XZ; Feng LY; Li SY; An GS; Ni JH; Jia HT
Biochem Pharmacol; 2009 Feb; 77(3):433-43. PubMed ID: 19014910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
